Accenture (NYSE:ACN) announced that insurance group Coverys is now
utilizing the Accenture
Duck Creek suite of software to support its property and casualty
insurance product development and policy, rating, billing and claims
Covidien plc (NYSE: COV) today announced, for purposes of the Irish
Takeover Rules, that the scheme of arrangement under which Medtronic
acquired Covidien under a new holding company incorporated in Ireland to
be named Medtronic plc has become effective.
is sponsoring the Retreat
& Refresh Stroke Camp (Stroke Camp), a three-day retreat for
stroke survivors, caregivers and family members dedicated to helping
these often forgotten victims of stroke relax and heal.
plc (NYSE:COV) today announced it has received CE Mark approval for its
Stellarex™ drug-coated angioplasty balloon (DCB). The Stellarex™ DCB is
used to restore and maintain blood flow to the arteries of the leg in
patients with peripheral arterial disease (PAD).
The Stellarex™ DCB is inserted into the diseased artery and inflated to
open the vessel and restore blood flow, while a drug called paclitaxel
is deposited onto the vessel wall to prevent the reoccurrence of new
Total revenue of $21.8 million Subscription revenue of $15.7 million Provides update on progress of strategic initiatives to refocus and position business for growth Named Senior Vice President, Products and Marketing Completed spin-off from Compuware Corporation DETROIT, Feb.
Cowen Group, Inc. (“Cowen”) (NASDAQ:COWN) today announced the formation
of an information and technology services investment banking group and
the appointment of Davies Beller and James Kissane as Managing Directors
and Co-heads of the new group.
Cowen Group, Inc. (“Cowen”) (NASDAQ:COWN) announced the release today of
its investor relations app for iPhone, iPad and Android mobile devices
now available for free at Apple’s
App Store for the iPhone and iPad and at Google
Play for Android mobile devices.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.